Menu
Prof. Ran Balicer MD, PhD, MPH
Chief Innovation Officer, Deputy CEO, Clalit Health Services
Prof. Ran Balicer is a physician, scientist and executive, Chief Innovation Officer for Clalit and as Founding Director, Clalit Research Institute, the WHO Collaborating Center. In these roles, he is responsible for implementation at scale of novel AI and data-driven interventions.
Prof. Balicer also serves as Chair of the Israel Society of Quality in Helathcare and Chairman of the National Experts Team on COVID-19.
Moshe Bar-Siman Tov
Director General, Israel Ministry of Health
Mr. Bar-Siman Tov has vast experience in directing large-scale public and governmental systems, and in leading strategic processes on the national level. He is deeply familiar with all aspects relevant to finance, healthcare, and regulatory systems. Mr. Bar-Siman Tov has led strategic and structural changes, as well as organizational innovation and digital transformation of the healthcare system in Israel.
Mr. Bar-Siman Tov is an economist, holding a master’sdegree from the Hebrew University of Jerusalem in Economics and Business Administration and spent 11 years in the Ministry of Finance. Prior to his position at the Ministry of Health, he served as the Economic Minster at the Israeli embassy in Washington D.C.
Prof. Rafael Beyar
Rambam & Technion
Managing General Partner, ALIVE Israel HealthTech Fund
Professor Emeritus, The Bruce and Ruth Rappaport Faculty of Medicine, Technion.
Co-Founder and Member, the Israeli National Academy for Science in Medicine.
President, International Friends Associations, Rambam Health Care Campus.
Interventional Cardiologist, Rambam Health Care Campus.
Managing General Partner: ALIVE Israel Health Venture Fund.
Adv. Yael Baratz
Senior Partner, Pearl Cohen Zedek Latzer Baratz
Yael Baratz is a name partner at Pearl Cohen Zedek Latzer Baratz, one of Israel’s most prominent IP law firms. Yael heads the corporate and licensing group, and has a wide range of experience in representing hi-tech and bio-tech companies, in both funding and technological collaborations. Yael also co-chairs the Israel Bar Association’s Law, Science and Technology Forum.
Prof. Dina Ben-Yehuda MD
Dean of the Hebrew University-Hadassah Medical School
Professor Dina Ben-Yehuda, MD, is an internationally recognized physician- scientist, hematologist and investigator in hematological malignancies research. She is the director of the Hematology Division at Hadassah University Medical Center and the Dean of the Faculty of Medicine, Hebrew University of Jerusalem. A graduate of the Ben-Gurion University Health Sciences Faculty, Ben-Yehuda completed her internship in internal medicine and hematology at Hadassah and post-graduate studies at the Center for Cancer Research at Memorial Sloan-Kettering in New York. She is treating patients with hematological malignancies and is leading innovative research in the treatment of malignant lymphoma using innovative approaches in combination with extensive clinical work. She is the leader of the Jerusalem Center for Computational Precision Medicine and Co-founder of the Sagol Program for Computational Medicine at The Faculty of Medicine.
Erez Ben Zvi
VP Medical, Stratasys
In his current role Erez leads the Medical business unit at Stratasys, overseeing the development of growth strategies, commercialization, and market activities.
Erez has over 16 years of experience in global senior roles in the medical device industry. Before joining Stratasys, Erez was General Manager of a startup company in the diabetic field and worked at 3D Systems Healthcare, including as Head of Global Market Development for POC solutions and product manager. Prior to that he led the clinical application product portfolio at Simbionix and held senior positions including quality and regulatory affairs at Paieon Medical. Erez is an industrial engineer and holds an MBA from Bar-Ilan University.
Shiran Blonder
Evidence Solution Manager, AbbVie Israel
Data and innovation-driven, leading new solutions and resources for research. Shiran holds a PhD in Medical Science from the Department of Genetics at Tel Aviv University and more than 9 years working with and in pharma research and industry.
Solomon Dadia MD
Head of the Levin Center for Surgical Innovation & 3D Printing, Orthopedic Oncology Surgeon, Tel Aviv Sourasky Medical Center
Dr. Dadia established the surgical 3D printing service in 2016, while acting as Deputy Director of Orthopedic Oncology of the National Unit at Sourasky and has played a pivotal role in introducing 3D planning and printing into major surgical disciplines, becoming a leader in defining the future standard of care with Israel’s Ministry of Health.
A lead surgeon and unique expert in complex orthopedic oncology surgeries, Dr. Dadia also has experience as a research associate in the MSk Lab at Imperial College London. Between 2014 and 2016, he worked there as a clinical advisor in a multidisciplinary team, researching software development and 3D printing and planning of patient-specific instruments, designed for bone tumor resection surgeries.
Today, Dr. Dadia is a sought-after lecturer, pioneering use of 3D printing technology in CMF, head & neck, pediatrics, spine, plastic reconstruction surgeries and more.
Dr. Yishay Falick MD, MBA
Director, HealthTech & Bioconvergence Technologies Innovation, Israel Aerospace Industries
HealthTech Entrepreneur: Co-founder and CEO of an Ophthalmic surgical platform startup company.
Health Systems Management expert: Former CEO of Misgav Ladach Hospital and the Director of the department for Hospitals’ standards and regulations in the Israeli Ministry of Health
An expert Ophthalmic surgeon: Recently leading a successful humanitarian delegation to Azerbaijan providing state-of-the-art Ophthalmic surgeries for wounded soldiers.
Dr Neta-li Feuerstein Ganor
Medical Head, Specialty Care, AbbVie Pharmaceuticals
Dr Neta-li Feuerstein Ganor is the Medical Affairs Head of Specialty Care Unit and Business Development Lead at AbbVie pharmaceuticals.
In her current role, Neta-li leads medical teams to execute AbbVie’s medical strategy in the Specialty Care Unit therapeutic areas including neuroscience, women’s health, hepatitis C and ophthalmology. Additionally, she leads the country’s Business Development arena, responsible for exploring the Israeli ecosystem for new technologies and platforms to augment Abbvie’s internal innovations efforts. Neta-li is a Doctor of Veterinary Medicine (DVM) from the Hebrew University of Jerusalem and holds an M.Sc. in Biological Sciences from Tel Aviv University.
Tili Fisher Yosef MD
GP & Medical Informatics Project Manager, Maccabi HealthCare Services
Podcaster, ISoH-Tech Fellowship Alumna
A specialist in Family Medicine with Maccabi Healthcare Services. Tili completed her studies at Tel Aviv University, and after her residency years she participated in the first cohort of the Israeli Society for HealthTech’s Fellowship in Medical Innovation and Entrepreneurship, working with MedAware and Microsoft’s Health Group. She now continues her medical work while managing digital projects at Maccabi’s Medical Informatics unit. Tili is also a podcaster talking about medical topics, a digital media presenter for KAN – Israeli Public Broadcasting Corporation, and a board member of the Briah Foundation for women’s health.
Yael Gruenbaum-Cohen DMD, PhD
Venture Partner, aMoon
Dr. Yael Gruenbaum-Cohen is a Venture Partner at aMoon fund. With 15 years of experience in the Healthcare space, Yael’s professional journey as a HealthTech investor is underlined by a patient-centric drive for success. Committed to advancing Israel’s HealthTech growth engine, she believes that through strategic investments we are able to transform and improve the lives of patients.
Prior to joining aMoon, Yael was a General at Medison Ventures, leading licensing, investments and strategic collaborations with global pharmaceutical companies and academic institutes. Before then, she led medical affairs for the Rare Disease division at Medison Pharma. Yael holds academic degrees in molecular genetics (PhD, Post doc) and a DMD from the Hebrew University of Jerusalem and the Weizmann Institute of Sciences.
Michal Guindy MD
Head of Ventures and Innovation, Assuta Medical Centers
Head of Ventures and Innovation, a board member of PathoLab Diagnostics and was head of medical imaging for the last seven years at Assuta Medical Centers.
She holds MD Ben-Gurion University Israel; Rradiology-Flinders, Australia. MPA Harvard Kennedy School. Conducts research & innovation initiatives in radiology, pathology, AI and ML and is involved in medical education as a faculty of BGU Medical School.
Previous managerial positions at Maccabi, including Risk Management & Patient Safety, laboratory, medical director.
Prof. Pinchas (Pinny) Halpern MD
Assoc. Professor (Emeritus) of Emergency Medicine, Anesthesiology, and Critical Care
Chair, Medical Oversight Board, Magen David Adom National EMS
Pinny received his MD from Tel Aviv University. He has over 40 years of experience in research and in technology development. He has led start-up companies, including cardiac output measurement from arterial pressure, peripheral blood flow measurement from PPG, diving equipment, resuscitation equipment, mechanical ventilation devices, remote monitoring devices, process optimization software, etc.
A specialist in Diving and Hyperbaric Medicine, Intensive Care and Emergency Medicine, Pinny is Associate Clinical Professor (Emeritus) in Emergency Medicine at Tel Aviv University and past President of the Israeli Association for Emergency Medicine and Chair, Division of Emergency Medicine, Tel Aviv University and Tel Aviv Medical Center 1993-2019. He has authored or coauthored >150 publications.
Eran Harary MD
SVP, Global Head of Innovative Medicines & Clinical Development, Teva Pharmaceuticals
Medical doctor and board certified in psychiatry. Eran has over 18 years’ experience in senior global leadership roles in international large pharmaceutical companies and smaller biotech companies – both in Israel and in the US (including Lundbeck and Pfizer Global Headquarters in New York, USA). Experienced in worldwide Lifecycle Management of pharmaceuticals from concept through all development stages to post-approval. Eran earned his MD degree from the Sackler School of Medicine in Tel Aviv, and later trained and practiced as a psychiatrist at the Chaim Sheba Medical Center, Tel Hashomer.
Dr. Irit Idan
Idan Technology Insights
Former EVP Research and Development, Rafael Advance Defense Systems
Lital Israeli-Yagev
Scientific and Regulatory Affairs Directorת ADRES Advanced Regulatory Services Ltd.
Lital has over ten years of experience in biopharmaceutics and biotechnology. She is experienced in scientific and regulatory affairs of drugs, biologics, devices, and combination product development. She oversees all activities of regulatory planning and submissions and participation in meetings with regulatory authorities around the globe. Lital leads her team to be creative and out-of-the-box thinkers and keep up to date with worldwide regulations. She navigates very complex projects in which she illuminates the regulatory pathway for the sponsor and balances scientific, regulatory, business, and market considerations to develop breakthrough solutions.
Lital gives lectures and serves as a mentor for clients and other stakeholders, such as academic programs, students, webinars, and more.
Prof. Dimitrios Karussis
Director of the MS Center, Hadassah MC
Prof. Dimitrios Karussis is Chairman of the Neuroimmunology Unit and MS Center at Hadassah and the MS/EAE neuroimmunology laboratory. He has published > 150 peer-reviewed scientific papersand delivered > 250 invited plenary lectures. He serves on the editorial board of many major journals. He has been member of the Executive Committee of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Prof. Karussis has pioneered studies with the novel immunomodulator, Linomide and with bone marrow and mesenchymal stem cell transplantation in MS. He is considered a world expert in the field of clinical applications of stem cells in neurological diseases. He has served as elected President of the Israeli Neuroimmunological society and as President of the World Congress of Neuroimmunology in Jerusalem.
Mgr. Michal Kfir
Business Strategy Director, Roche Pharmaceuticals (Israel) Ltd.
Business Strategy Director at Roche Pharmaceuticals (Israel) Ltd., with an academic background in Pharmaceuticals Sciences (M Sc.), and Health Administrations (MHA).
Well experienced in the Market Access arena, specifically with reimbursement processes in Israel and in Europe.
Idit Lachover-Roth MD
Senior physician at the Allergy and Clinical Immunology Unit, Meir Medical Center
Idit is senior physician at the Allergy and Clinical Immunology unit, MMC, Israel where she heads the Neutrophil Function Laboratory and is a member of the Meir Medical Center ethical committee. Idit is also a lecturer at the Sackler Faculty of Medicine, Tel-Aviv, Israel.
She is a member in the executive committee of the Israel Association of Allergy and Clinical Immunology. She has a BSc in Biology and Psychology from Bar-Ilan University, and MD from the Faculty of Medicine, Technion – Israel Institute of Technology. She is board-certificate in Pediatrics and in Allergy and Clinical Immunology and graduate the first fellowship in HealthTech, Israeli Society for HealthTech. Beyond her clinical job, she is an entrepreneur who has applied provisionals for prevention of food allergy and recognizing allergic reactions.
Uri Lerner PhD
Project Manager, Data & Modeling, Medical Informatics Department, Maccabi Healthcare Services
Uri Lerner, PhD, is a medical informatics specialist at Maccabi Healthcare Services, a health maintenance organization in Israel. His primary focus is health data and advanced modeling, with a particular emphasis on incorporating data-driven knowledge into the daily work of physicians. Uri serves as the organizational FHIR lead and is a top contributor to the national IL CORE team on a range of topics, working to create a cohesive data representation of the national, organizational, and local aspects in Israel’s healthcare ecosystem. Uri is a strong proponent of a multidisciplinary approach to problem-solving and aims at learning something new each day.
Prof. Noah Liel-Cohen MD
Professor Emeritus, Faculty of Health Sciences, Ben Gurion University of the Negev
Co-Founder, Dia Imaging Analysis
Professor emeritus at the Faculty of Health Sciences at Ben Gurion University and former head of the Echocardiography Unit at Soroka Medical Center, Beer Sheva. Noah is Co-founder of DiA Imaging Analysis, a company developing AI tools for analysis of ultrasound images. She is a member of 8400 – The Health Network, and Co-founder of the Israeli Society for HealthTech where she heads the Fellowship Program and Education Committee. She is involved in global health, assisting implementation of echocardiography services in low-income countries; she is also the academic coordinator of the global health clerkship at the Medical School for International Health (MSIH) at Ben Gurion University.
Prof. Anat Loewenstein MD, MHA
Chairman of the Department of Ophthalmology, Tel Aviv Sourasky Medical Center
Professor of Ophthalmology, Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center, Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, President of the Israeli Ophthalmological Society and the General Secretary of the Euretina board.
Her main field of interest is the investigation of drug administration and toxicity to the retina, early detection of macular degeneration and home monitoring of retinal disease. She has been leading several cutting-edge technologies implemented in large-scale clinical trials and in clinical settings: the home OCT, a first-of a -kind artificial intelligence-enabled algorithm for monitoring retinal diseases, utilizing an OCT device in the patient’s own home, and the development of a technology implementing virtual reality in vitreoretinal surgery.
Israel Lupa
Executive VP and CTO, ELTA Systems Ltd. – a subsidiary of Israeli Aerospace Industries
Mr. Israel Lupa is leading the technological vision of ELTA, empowering R&D, innovation, future technology research, cooperation with start-ups, partners and research institutes and the development of new business verticals.
He is also Chairman of Board of Directors of Gal EL, a GaAS and GAN Fab.
Previously he was General Manager of ELTA’S Land & Naval Radars and Systems Division, which offers solutions for surveillance, situational awareness, point and area protection, air/naval defense, artillery, missile support and EEZ/homeland security. Throughout his 35 years at ELTA, Mr. Lupa has held several key positions in both the engineering and executive domains. This includes leading the creation of the Ground-Based Radar Division and the development and introduction of the first “fully digital” Phased Array Radar.
Miri Mizrahi Reuveni MD, MHA
Deputy CEO and Head of the Health Division at Maccabi Healthcare Services
Deputy Director General and Head of the Health Division at Maccabi Healthcare Services. She holds an MD degree from Ben-Gurion University as well as an MHA degree from Tel Aviv University. She is board certified in Family Medicine and Healthcare Management. Dr. Mizrahi-Reuveni is a member of the 8400 Health Network and Co-founder and acting secretary of the Israeli Society for HealthTech.
She is currently leading the development and implementation of novel healthcare services, aiming to improve both individual and population ealth. Dr. Mizrahi-Reuveni serves as Director in a data-driven digital health company.
Safwat Odeh MD
Israeli Society for HealthTech Fellowship Alumnus; Gastroenterologist, Bnai Zion Medical Center
Gastroenterologist at Bnai Zion Medical Center in Haifa and Maccabi Healthcare Services. His practice focuses on inflammatory bowel diseases and the gastrointestinal microbiome. Safwat is a graduate of Tel Aviv University’s Faculty of Medicine. He trained at the Bnai Zion Medical Center’s Department of Internal Medicine, followed by training in the Gastroenterology and Liver Diseases Unit.
He also works as a medical consultant at Jubaan Ltd, a startup developing an early detection system for GI disorders. inflammatory bowel diseases and the gastrointestinal microbiome.
Safwat is a graduate of the first cohort of the Fellowship in Medical Innovation and Entrepreneurship.
Eran Peleg
GM R&D, PoC Ultrasound, GE HealthCare
Eran is Global R&D leader for Point of Care Ultrasound at GE HealthCare. In this role, he leads the development of cutting-edge product strategies and collaborates with cross-functional teams to ensure that technical solutions meet customer needs and requirements. He also serves as Site Leader in Haifa, fostering a culture of collaboration, diversity, and development within the team.
Prior to joining GE HealthCare, Eran spent nearly 20 years at Intel in senior engineering leadership roles across a wide range of products. In his most recent role at Intel, he served as Senior Director and Portfolio Engineering Manager for the Smart Network Interface Controller product line, overseeing projects and activities worth approximately $1 billion and managing global teams across geographies.
Eran earned his Bachelor of Science in electrical engineering from the Technion, Israel Institute of Technology in Haifa.
Dr. Tamar Raz
CEO, Hadasit – Hadassah Technology Transfer Company
Dr. Tamar Raz has nearly two decades of experience in technology transfer and an impressive track record of bringing medical innovations from the lab to the marketplace. Prior to joining Hadasit, she served as VP of Marketing and Strategy at Ramot, the technology transfer company of Tel Aviv University. Tamar was the founder and CEO of Allergene Ltd, an Israeli drug development start-up company. She received her MSc and PhD in cell biology from the Tel Aviv University School of Medicine.
Prof. Michal Rosen-Zvi PhD
Director, AI for Healthcare and Life Sciences, IBM Research
Prof. Rosen-Zvi is the Director, AI for Drug Discovery at IBM Research and an adjunct Computational Medicine Professor at the Hebrew University at the Faculty of Medicine. She is also heading the AI for accelerated HC&LS discovery department at IBM Research, Israel. Michal holds a PhD in computational physics and completed her postdoctoral studies at UC Berkeley, UC Irvine, and the Hebrew University in the area of Machine Learning. She joined IBM Research in 2005 and has since led various projects in the area of machine learning and healthcare. Michal has published more than 50 peer-reviewed papers. She is a member of the iScience Editorial Advisory Board, a member of the Israeli National Council of Digital Health and Innovation and an elected member of the Board of the Israeli Society for HealthTech.
Shirley Shapiro Ben David MD
Director, Infectious Diseases Unit, Maccabi Healthcare Services
Shirley Shapiro Ben David graduated from Hadassah Medical school, Hebrew University and then specialized in family medicine.She completed a Fellowship in Infectious Diseases and continued working in the Infectious Disease Unit at Wolfson Medical Center as a senior ID physician until 2022.
Since 2021 she is Head of the Infectious Disease Unit and Chief Consultant in Maccabi Healthcare Services.
Her current research/scientific interests focus on vaccine-preventable infections, antimicrobial stewardship, the efficacy and safety of vaccines against COVID-19 and COVID-19 care in the community. Shirley has contributed peer-reviewed articles publications and has presented her research work in national and international congresses. She is a member of the Israeli Society of Family Medicine, Israel Association of Public Health Physicians, the Israeli HIV Medical Society, the Israeli Infectious Diseases Society and IDSA.
Yossi Shaya MD, MBA
Rabin Medical Center Innovation, Deputy Chief of Rabin Medical Center Emergency Department.
Yossi holds an medical degree and MBA in healthcare innovation. He is dedicated to improving the intersection between medicine, technology and business.
Shachaf Snir
Director of Internal Innovation, Clalit Health Services
Shachaf is married to Naama and father to Amit and Karni – his biggest achievements so far.
Shachaf is also an innovation professional with more than a decade of experience designing innovative organizations, working in companies such as Amdocs and Bank Hapoalim, as well as consulting for many other firms.
Today Shachaf is leading the Internal Innovation Unit at Clalit Innovation – the innovation arm of Clalit Health Services.
Hedva Voliovitch MD, PhD, MBA
Chair of the Israeli Society for HealthTech
Cofounder and Chair of the Israeli Society for Health Tech. Hedva has more than 20 years’ experience in the field of drug development, R&D, and safety of medicinal products. She established the Global Pharmacovigilance division at Teva Pharmaceuticals and served as the company’s Senior VP for Global Pharmacovigilance and Patient Safety. She is a consultant for biotech companies on drug development, drug safety and pharmacovigilance.
Hedva received her MD from Tel Aviv University, as well as a PhD in Molecular Biology from the Weizmann Institute of Science and an MBA degree from IDC Herzliya (now Reichman University).
Irit Yaniv MD, MBA
Founding Partner and CEO, Almeda Ventures
Co-founder and CEO of Almeda Ventures, a healthtech-focused public R&D partnership, traded in Tel-Aviv Stock Exchange. Almeda’s portfolio currently includes 10 companies. Irit has more than 25 years of experience in operational and venture investments in the healthtech industry. She has been serving as a partner at Accelmed since 2012, leading a number of companies from development through acquisition. She is also co-founder of two clinical-stage medical device companies, Digma Medical and Nitinotes.
Roy Zaibel
Co-CEO, Partnerships, Business Development & Marketing, ADRES Advanced Regulatory Services Ltd.
Roy joined ADRES in early 2017 to take over the company’s management. Since then, ADRES has almost doubled in size and in business. Roy mainly focuses on internal and external communications and connecting and bonding with the life sciences stakeholders, such as Academic Institutions, Tech Transfer Offices, Hospitals and Clinical Centers, Hubs and Accelerators, VCs and Investors, Governmental and non-Profit Organizations, Law Firms, Industry Service Providers and more. Roy is always seeking to broaden ADRES’s network, realizing that partnerships and collaborations are a vital engine of the Israeli Life Sciences Industry. He is also working on expanding ADRES’s activities globally by starting ADRES EU in 2019 and by connecting with stakeholders in Europe, the USA, Asia, and more.
Tovi Carmon
COO, Jubaan
An accomplished businesswoman with over 25 years of diverse experience as an entrepreneur, management, and marketing leader, having worked with some of Israel’s leading industrial companies. Tovi is Chief Operations Officer at Jubaan, a start-up company using AI technology for medical devices. Tovi established a unique innovation Center at Amal and Beyond, the leading Israeli genealogy cooperation. She was co-founder of Orpheus Medical, which was acquired successfully by Intuitive Surgical, and was CEO of Momesense, a signal processing company.
David Rainis
Co-Founder, CEO, Jubaan
David is a serial entrepreneur with expertise in deployment of large-scale systems in the international hi-tech markets; specializing in AI and deep learning, DSP and image processing and communications.
Execution of 7 exits; most recently Orpheus-Medical, acquired by Intuitive Surgical.
Jubaan has developed an AI imaging platform for early detection of GI (gastrointestinal) disorders, using images of the tongue. By utilizing cutting-edge artificial intelligence and deep learning technologies, Jubaan is set to become a game-changer for early detection of GI disorders, saving the healthcare industry valuable resources and most importantly saving lives by providing better and expedient patient outcomes.
Mira Altmark-Sofer, EMBA
VP Marketing, Pulsenmore – Home Ultrasound
MedTech executive with extensive experience in medical innovation. Proven track record in building commercial and marketing strategy and developing market access for innovative medical technologies.
Driven by passion to positively impact human lives with healthcare innovation and make a real difference in the way care is delivered worldwide.
Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening. Our home ultrasound solutions improve access and continuity of care, providing efficiency that benefits clinicians and patients alike.
Proud to be leading the transformation in the field of ultrasound, by allowing patients to take control over their medical condition in partnership with their healthcare providers.
Tal Arnon
CEO, DrugsIntel
Married + 5
Formerly Vice President of International Business Development SK-Pharma Group
Rich and varied management experience: Champion Motors (Audi Seat CEO); Globus Max (Network Manager); National Library; Self Independent company for business management and business support
Holds a degree in political science and foreign affairs. Reserve lieutenant colonel.
Chairman of the parent leadership in Shoham.
DrugsIntel has developed an exclusive technological platform, “The Compass” that aggregates unique medical data sets and applies manipulation, unification and deployment of the data to a business intelligence report using AI and ML and NLP models. The Compass is designed to guide orphan drugs companies towards successful launch of their orphan drugs, based on the 6 pillars of success methodology. The Compass provides an eagle eye view of the orphan drug market opportunities in 65 countries and counting, with a mission of answering unmet needs for patients and their caregivers dealing with rare diseases.
Shira Shaham-Niv, PhD
VP R&D, MetaSight Diagnostics
Shira is VP R&D at Metasight Diagnostics, a stealth-mode start-up company with a unique set-up for developing diagnostic biomarkers. She joined the company as its first employee, responsible for setting up the company’s labs and offices. Today, she heads all R&D projects and leads collaborations with diagnostic and pharma companies. Previously, Shira established and was head of a metabolomics division at the BLAVATNIK CENTER for Drug Discovery at Tel Aviv University, where she promoted the center’s industry-academy relations. Shira completed her PhD and post-doctoral studies at Tel Aviv University, and has been translating several projects into an academia-industry collaboration. Her work has been published in leading peer-reviewed journals.
MetaSight develops novel diagnostic methods based on proprietary technology for cost-effective mass-spectrometric multi-OMICS analysis of serum samples, initially focusing on chronic liver diseases, oncology, and cardiovascular conditions. Towards this aim, MetaSight currently runs the world largest serum molecular profiling trial with 500,000 people – the Israeli multi-OMICS Serum Screening project (IMOSS-500K), integrating molecular and EHR data.
Dr. Eddie Price
CEO & Medical Director, eHealthier
A professional medical practitioner with more than 30 years in managing & innovating creative healthcare solutions. Currently founder of eHealthier. Authored and published 3 books on the subject of value and outcome-based healthcare to explain how medicine and e-health can be used to measure, monitor and improve the wellbeing of individual patients and the general population.
eHealthier is a cloud-based personalised digital medicine platform (incorporating Preventive Value Based Healthcare).
It disrupts healthcare by focusing on preventive, personalized, and participatory medicine.
With cutting-edge AI and big data analysis, it delivers purpose-fit insights and population health trends, reduces healthcare costs, estimated at annually 8% and enhances patient experiences.
Hospitals: eHealthier for hospital will radically improve your hospital’s Newsweek ranking for The World’s Best Hospitals.
PLATINUM SPONSOR & EXHIBITOR
Visit GE HealthCare’s stand where you can see the most advanced ultrasound solutions in real-time use.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.
Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.
Eran Peleg
GM R&D, PoC Ultrasound, GE HealthCare
SILVER SPONSOR & EXHIBITOR
Visit the Israel Aerospace Industries stand to find out how our innovations are applied for tomorrow’s healthcare.
In a fast-evolving world, you need experienced and skillful allies to rely on. A trusted partner, courageous and innovative to deliver the capabilities you need and afford. That’s IAI – Where Courage Meets Technology.
Leveraging decades of experience in developing and supplying innovative, cutting-edge systems for customers around the world, we deliver optimized, state-of-the-art technologies and systems in all domains.
As industry leaders, we understand that we bear responsibility for the impact we have on the world, in every area of our operations. That’s why we are working towards a more sustainable future, and why we see honoring our social obligations as a top priority.
Innovation is the cornerstone of IAI’s success as a company, and we invest considerable resources in researching and developing the technologies of the future – both in military and civilian markets. The CTO’s team at IAI leads these efforts and is at the forefront of the company’s strategy. IAI is a significant player in the global innovation ecosystem – The company’s business divisions engage extensively with startups, and we continue to support, develop and nurture local and international industry
Dr. Yishay Falick MD, MBA
Director, HealthTech & Bioconvergence Technologies Innovation, Israel Aerospace Industries
BRONZE SPONSOR
Join us in the scientific program to hear about AbbVie’s strategy for external innovation and patient care, and at our unique round table discussion on real-world data.
Abbvie is a global biopharmaceutical company with over 135 years of research. Our mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people’s lives. Our main therapeutic areas include Immunology, Oncology, Neuroscience, Eye Care and Aesthetics. We invest and innovate relentlessly to tackle unmet needs, creating new medicines and healthcare solutions for a healthier world.
Abbvie is Ranked 2nd as Great Place to Work within the Pharma industry with over 50,000 employees worldwide working in 70 different countries, to improve patients’ lives. Over 62 million people around the world are treated with AbbVie products annually, and take part in our Patient Support Programs, in order to live better and healthier lives.
At the Israeli affiliate we are 180 employees, working together to share professional knowledge, establish clinical trials and improve access to our treatments.
Shiran Blonder PhD
Evidence Solution Manager, AbbVie Israel
BRONZE SPONSOR
Visit our stand and sign up to join our round table at the summit.
ADRES’s team of consultants guides startups and established companies in the healthtech industry as they navigate complex medical regulatory environments.
From novel medical devices to new biopharma creations and technologies, ADRES has the experience and relationships to secure regulatory approval in the United States, Europe, Israel, and globally.
ADRES clients operate in multiple fields, in the pursuit of treatments for an array of medical conditions.
Our European subsidiary ADRES EU B.V. is located in Amsterdam and serves as the European Representative during the conduct of clinical trials, as well as the European Representative for CE-marked medical devices.
Rivka Zaibel
President and Founder, ADRES
Roy Zaibel
Co-CEO, ADRES
Tanya Fineman
Client Success Lead & Marketing, ADRES
Lital Isreali Yagev
Scientific and Regulatory Affairs Director, ADRES
BRONZE SPONSOR
We look forward to meeting you at the summit and to discussing innovation protection at our round table.
An international law firm, with more than 200 admitted attorneys and patent attorneys throughout the United States, Israel, and the United Kingdom, Pearl Cohen’s priority is to provide innovative legal advice with maximum commercial impact.
For decades, our commitment to innovation and excellence has been earning the confidence of innovation-driven enterprises, including Fortune 500 and small-cap emerging companies, start-ups and entrepreneurs, investors, academic institutions, and government-related entities.
Our clients recognize the excellence of our strong team of multilingual professionals, educated in some of the world’s most renowned legal, academic, and scientific institutions, with experience from the world’s most prominent law firms. As such, our international perspective is entrenched in the DNA of the firm – introduced by the partners, reinforced by the associates, and valued by our clients.
Adv. Yael Baratz
Senior Partner, Pearl Cohen Zedek Latzer Baratz
BRONZE SPONSOR
Join us for our exciting panel discussion on Healthcare Innovation: Applications of Digital Health in Clinical Practice
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.
Mgr. Michal Kfir
Business Strategy Director, Roche Pharmaceuticals (Israel) Ltd.
SPONSOR & EXHIBITOR
Learn about our solution at our stand!
Alpaca is an ERP solution for medical centers and hospitals of any kind. We have an all-in-one solution, including CRM, EMR, Marketing, Finance, SCM, HRM, apps and web services, that helps greatly increase hospital running efficiency and patient experience. Our special focus is on cyber security – secure by default approach, modern architecture, no PII in clouds.
SPONSOR
We will be at the ISoH-Tech summit to discuss innovation in healthtech and to present Israel’s Annual HealthTech Ecosystem Report.
aMoon is a global HealthTech and life sciences investment fund headquartered in Israel. As Israel’s largest HealthTech VC fund, aMoon partners with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare and help people live better, healthier lives.
aMoon harnesses its multidisciplinary team of over 50 scientists, physicians, and entrepreneurs, along with its robust network of investors and industry leaders, to build bridges between its portfolio companies and global HealthTech hubs to help entrepreneurs from the inception of an idea to the company launch.
aMoon’s platform includes three HealthTech investment vehicles; aMoon Velocity, its early-stage fund, aMoon Growth, its late-stage fund, and aMoon Edge, its boutique, concentrated, hedge fund that invests in small to mid-cap companies.
Yael Gruenbaum-Cohen DMD, PhD
Venture Partner, aMoon
SPONSOR & EXHIBITOR
Get hands on with Clalit’s latest innovative solutions at our stand.
Clalit Innovation is your gateway to innovation within Clalit, Israel’s leading national health organization comprising over 4.7 million members. As Israel’s largest national health organization, we have access to the largest data assets, an interdisciplinary team of experts, and a unique position on interconnectivity. By translating data and know-how into innovative insights and digital health tools, Clalit Innovation redesigns care to provide proactive, predictive, and tailored medical care in everyday practice.
Clalit’s innovation network includes 13 innovation centers, situated in our hospitals and the community. Each has a unique purpose and characteristics, based on real-life needs that clinicians, therapists, and other employees encounter every day.
Clalit’s innovation centers share their accumulated knowledge and projects, whether they are cross-organizational or cross-clinical.
SPONSOR
Don’t miss our Rapid Fire pitch!
DrugsIntel has developed an exclusive technological platform, “The Compass” that aggregates unique medical data sets and applies manipulation, unification and deployment of the data to a business intelligence report using AI and ML and NLP models. The Compass is designed to guide orphan drugs companies towards successful launch of their orphan drugs, based on the 6 pillars of success methodology. The Compass provides an eagle eye view of the orphan drug market opportunities in 65 countries and counting, with a mission of answering unmet needs for patients and their caregivers dealing with rare diseases.
Tal Arnon
CEO, DrugsIntel
SPONSOR & EXHIBITOR
Meet us at our stand and catch our Rapid Fire pitch to learn about the benefits of our platform.
eHealthier is a cloud-based personalised digital medicine platform (incorporating Preventive Value Based Healthcare).
It disrupts healthcare by focusing on preventive, personalized, and participatory medicine.
With cutting-edge AI and big data analysis, it delivers purpose-fit insights and population health trends, reduces healthcare costs, estimated at annually 8% and enhances patient experiences.
Hospitals: eHealthier for hospital will radically improve your hospital’s Newsweek ranking for The World’s Best Hospitals.
Dr. Eddie Price
CEO & Medical Director, eHealthier
Ms. Rachel Kaiser
Israel Representative, eHealthier
SPONSOR & EXHIBITOR
Meet us at our stand to find out more about advanced research and diagnostic solutions for labs and hospitals.
For over thirty years Enco Scientific Services and Enco Diagnostics have provided access to a wide range of research and diagnostic materials to labs and hospitals in Israel. Additionally, our customer base in the private sector is constantly growing.
While Enco Scientific Services specializes in antibodies, enzymes, reagents, controls, stem cell technology, detection systems, and the like, Enco Diagnostics offers products for coagulation labs, pathology labs, bone health, Crohn’s disease, point of care, and more. Both companies also deal with the marketing of flow cytometers reagent.
Some of the major companies we work with are Stem Cell Technology, Perkin Elmer, Biolegend, Quidel-Ortho and Behulman and we are constantly on the lookout for new developments relevant to our customers’ concerns. Our staff is able to advise and meet the needs of the Israeli research community.
Chai Gridish MSc
Product Manager, Enco Diagnostics
Viktoria Raz
Product Manager and Business Development, Enco Diagnostics
SPONSOR
We will be at the ISoH-Tech summit to talk about how to navigate the complexities of taking an idea from concept to market.
Dr. Tamar Raz
CEO, Hadasit – Hadassah Technology Transfer Company
SPONSOR
Don’t miss our Rapid Fire pitch!
Jubaan has developed an AI imaging platform for early detection of GI (gastrointestinal) disorders, using images of the tongue. By utilizing cutting-edge artificial intelligence and deep learning technologies, Jubaan is set to become a game-changer for early detection of GI disorders, saving the healthcare industry valuable resources and most importantly saving lives by providing better and expedient patient outcomes.
Tovi Carmon
COO, Jubaan
David Rainis
Co-Founder, CEO, Jubaan
SPONSOR & EXHIBITOR
Don’t miss this opportunity to check out the most innovative smart desk for medical staff at our stand.
Medicine has taken a massive leap in the last decade – However – we’ve gone from 0 to 60 in a short span of time. Medical staff is inundated with technology – an average of 5-6 programs or devices that they must utilize and update.
MedDesk is a command and control, integrated all-in-one smart desk for medical staff – enabling simplified workflow and sharing of records – freeing the doctor for the most important tasks – patient face time.
The product is an intuitive, integrated all-in-one device.
• Fully functional, Ultra-wide touch screen
• Advanced Platform for Built in AI data assistant and analysis
• Built-in camera, mic, and speakers for Telemedicine ready
• Automated transcription, dictation, and voice commands (hands free)
Shai Harel
Co-founder – CEO, MedDesk
SPONSOR
Don’t miss our Rapid Fire pitch!
MetaSight develops novel diagnostic methods based on proprietary technology for cost-effective mass-spectrometric multi-OMICS analysis of serum samples, initially focusing on chronic liver diseases, oncology, and cardiovascular conditions. Towards this aim, MetaSight currently runs the world largest serum molecular profiling trial with 500,000 people – the Israeli multi-OMICS Serum Screening project (IMOSS-500K), integrating molecular and EHR data.
Shira Shaham-Niv, PhD
VP R&D, MetaSight Diagnostics
SPONSOR & EXHIBITOR
Meet our team at our stand where we’ll be talking about innovation for the treatment of massive bleeding.
PLAS-FREE Ltd, founded in 2017, is a HealthTech clinical-stage company, specializing in developing and commercializing disruptive devices to treat massive bleeding.
Plas-Free has completed a successful clinical study treating upper gastro internal bleeding patients. These days the company is performing an additional clinical study in cardiac operations. The company is a few months before CE mark approval.
SPONSOR
Don’t miss our Rapid Fire pitch!
Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening. Our home ultrasound solutions improve access and continuity of care, providing efficiency that benefits clinicians and patients alike.
Proud to be leading the transformation in the field of ultrasound, by allowing patients to take control over their medical condition in partnership with their healthcare providers.
Mira Altmark-Sofer, EMBA
VP Marketing, Pulsenmore – Home Ultrasound
SPONSOR
Attend the “Introducing New Technologies to the Healthcare Community – Challenges and Opportunities” panel where our SVP Eran Harary MD will be sharing key insights.
In a complex world, Teva’s mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.
We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,600 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva’s quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine.
Eran Harary MD
SVP, Global Head of Innovative Medicines & Clinical Development, Teva Pharmaceuticals
TABLE 1
Can your Employer Own Your Brain (Or at Least Part of It)?
How to Maximize Your Rights
TABLE 2
Real World Data: Opportunities vs Challenges
We’ll be taking a deep dive into intellectual property rights of employees vis-à-vis employers, regarding their inventions; disclosure procedures, collaborations; how inventions are “packaged” for commercialization; the role of technology transfer organizations in technology commercialization; methods for collaborating with industry: license agreements, service units, sponsored research and consultancy.
Sponsored by:
Moderators:
Adv. Yael Baratz
Senior Partner, Pearl Cohen Zedek Latzer Baratz
Idit Lachover-Roth, MD
Senior physician at the Allergy and Clinical Immunology Unit, Meir Medical Center
Dr. Tamar Raz
CEO, Hadasit – Hadassah Technology Transfer Company
Growth in the availability and variability of novel real world data sources and tools has opened the door to better understanding, managing, and following up on diseases and new therapies “beyond the clinic” with the aim of improving health outcomes. We will look into the usefulness of novel data, map the identified local challenges and try to further explore key frameworks and practical next steps for RWD use.
This discussion may be of interest to practitioners, researchers, innovation leaders, data scientists, and health technology professionals to participate.
Sponsored by:
Moderators:
Yossi Shaya MD
Deputy chief of Emergency Department, Rabin Medical Center
Eddie Price MD
CEO & Medical Director, eHealthier
Shiran Blonder PhD
Evidence Solution Manager, AbbVie Israel
TABLE 3
The Dynamics of Starting up a Startup – Outsourcing, Insourcing and Hybrid Approaches
TABLE 4
Is It Enough to Be a Clinician? How About Getting to Know Healthtech?
How should entrepreneurs set up their startup’s operations? Which aspects must be outsourced/ insourced, and for which aspects do you need to decide for yourself? In this roundtable, we’ll discuss the considerations and the alternatives that you’ll need to guide you through the process. We’ll illuminate how this approach changes throughout the startup’s progression.
Sponsored by:
Moderators:
Roy Zaibel
Co-CEO, ADRES
Lital Israeli Yagev
Scientific and Regulatory Affairs Director, ADRES
Engaging medical personnel in healthcare innovation fosters creativity, critical thinking, problem-solving skills, and an entrepreneurial mindset, which is essential for driving positive change in healthcare and may even prevent burnout. We discuss the importance of early education for healthcare innovation and entrepreneurship. How could providing the right tools enable a better understanding of the challenges faced by the healthcare system? Will it make them better doctors later in their careers?
Coordinated by:
Moderators:
Prof. Noah Liel-Cohen MD
Professor Emeritus, Faculty of Health Sciences, Ben Gurion University of the Negev
Co-Founder, Dia Imaging Analysis
Dr. Safwat Odeh
Israeli Society for HealthTech Fellowship Alumnus; Gastroenterologist, Bnai Zion Medical Center
Co-Founders of the TAU MedTech Hackathon:
Orr Erlich, Tom Zuckerman, Yael Lieber
Medical students
TABLE 1
Can your Employer Own Your Brain (Or at Least Part of It)?
How to Maximize Your Rights
We’ll be taking a deep dive into intellectual property rights of employees vis-à-vis employers, regarding their inventions; disclosure procedures, collaborations; how inventions are “packaged” for commercialization; the role of technology transfer organizations in technology commercialization; methods for collaborating with industry: license agreements, service units, sponsored research and consultancy.
Sponsored by:
Moderators:
Adv. Yael Baratz
Senior Partner, Pearl Cohen Zedek Latzer Baratz
Idit Lachover-Roth, MD
Senior physician at the Allergy and Clinical Immunology Unit, Meir Medical Center
Dr. Tamar Raz
CEO, Hadasit – Hadassah Technology Transfer Company
TABLE 2
Real World Data: Opportunities vs Challenges
Growth in the availability and variability of novel real world data sources and tools has opened the door to better understanding, managing, and following up on diseases and new therapies “beyond the clinic” with the aim of improving health outcomes. We will look into the usefulness of novel data, map the identified local challenges and try to further explore key frameworks and practical next steps for RWD use.
This discussion may be of interest to practitioners, researchers, innovation leaders, data scientists, and health technology professionals to participate.
Sponsored by:
Moderators:
Yossi Shaya MD
Deputy chief of Emergency Department, Rabin Medical Center
Eddie Price MD
CEO & Medical Director, eHealthier
Shiran Blonder PhD
Evidence Solution Manager, AbbVie Israel
TABLE 3
The Dynamics of Starting up a Startup – Outsourcing, Insourcing and Hybrid Approaches
How should entrepreneurs set up their startup’s operations? Which aspects must be outsourced/ insourced, and for which aspects do you need to decide for yourself? In this roundtable, we’ll discuss the considerations and the alternatives that you’ll need to guide you through the process. We’ll illuminate how this approach changes throughout the startup’s progression.
Sponsored by:
Moderators:
Roy Zaibel
Co-CEO, ADRES
Lital Israeli Yagev
Scientific and Regulatory Affairs Director, ADRES
TABLE 4
Is It Enough to Be a Clinician? How About Getting to Know Healthtech?
Engaging medical personnel in healthcare innovation fosters creativity, critical thinking, problem-solving skills, and an entrepreneurial mindset, which is essential for driving positive change in healthcare and may even prevent burnout. We discuss the importance of early education for healthcare innovation and entrepreneurship. How could providing the right tools enable a better understanding of the challenges faced by the healthcare system? Will it make them better doctors later in their careers?
Coordinated by:
Moderators:
Prof. Noah Liel-Cohen MD
Professor Emeritus, Faculty of Health Sciences, Ben Gurion University of the Negev
Co-Founder, Dia Imaging Analysis
Dr. Safwat Odeh
Israeli Society for HealthTech Fellowship Alumnus; Gastroenterologist, Bnai Zion Medical Center
Co-Founders of the TAU MedTech Hackathon:
Orr Erlich, Tom Zuckerman, Yael Lieber
Medical students
Miri Mizrahi Reuveni MD
Deputy CEO and Head of the Health Division, Maccabi Healthcare Services
Irit Yaniv MD, MBA
Founding Partner and CEO, Almeda Ventures
Noah Liel-Cohen MD
Professor Emeritus, Faculty of Health Sciences, Ben Gurion University of the Negev
Co-Founder, Dia Imaging Analysis
